Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Puretech Health plc
Headquarters: Boston, MA, United States of America
Website: http://www.puretechhealth.com...
Year Founded: 2001
Status: Public
Industry Sector: HealthTechnology
CEO: Bharatt M. Chowrira, PhD
Number Of Employees: N/A
Enterprise Value: $374,445,323
PE Ratio: -6.09
Exchange/Ticker 1: LSE:PRTC
Exchange/Ticker 2: NASDAQ:PRTC
Latest Market Cap: $455,390,628
BioCentury | Nov 6, 2024
Management Tracks
SOBI to propose David Meek as chair
Plus: Seaport hires Lauren White as CFO, and updates from Tarsus and Takeda
BioCentury | Oct 25, 2024
Finance
Septerna’s GPCRs draw strong demand in $288M IPO
BioCentury’s Financial Report: ProQR’s $75M raise, Seaport’s $225M series B and more
BioCentury | Jun 21, 2024
Management Tracks
ITM names Cavey CEO, plus PureTech, Brainstorm and more
Plus: New chairs for PureTech, Evexta and updates from PharmaEssentia, Brainstorm, Danaher and more
BioCentury | Jun 19, 2024
Management Tracks
Seaport adds Loebel as CMO, Gladstein as general counsel
Plus: SpyBiotech names Keith Dewedoff CFO, and updates from Kriya, CytomX and Progentec
BioCentury | May 7, 2024
Management Tracks
Seaport rounds out C-suite with new hires
Plus: Germany-based Topas taps new CEO, and updates from Quest, Nimbus and more
BioCentury | Apr 12, 2024
Finance
Venture report: Torl doubles its series B funding in Deep Track-led B2
Plus: PureTech’s Seaport launches, and updates from Nvelop, D3 Bio and more
BioCentury | Apr 10, 2024
Management Tracks
PureTech’s Zohar takes CEO role at new portfolio company targeting CNS
Plus: AskBio hires former Prevail CSO, and updates from Illumina, Xencor, Adcentrx, enGene and more
BioCentury | Apr 9, 2024
Emerging Company Profile
Karuna team, backers reunite for neuropsychiatry play Seaport’s launch
PureTech’s Zohar, Karuna’s Paul among team advancing prodrug candidates for anxiety and depression that avoid hepatic absorption
BioCentury | Mar 22, 2024
Finance
Public equity report: Galderma rises after $2B IPO; Contineum, Boundless prep U.S. listings
Plus Madrigal’s follow-on is among the year’s largest, and PureTech returns cash to shareholders following Karuna takeout
BioCentury | Dec 23, 2023
Deals
Persistence, creative combinations behind Karuna’s $14B exit
BMS acquires Karuna, brightening the spotlight on schizophrenia, muscarinic receptors and neurology
Items per page:
1 - 10 of 131